VerAvanti Overview

  • Founded
  • 2012

  • Status
  • Private

  • Employees
  • 9

  • Latest Deal Type
  • Debt - PPP

  • Investors
  • 2

VerAvanti General Information


Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events. The company's device consists of an imaging station and a tiny catheter that is designed to take high definition images, enabling doctors and surgeons to have a peek into hidden intra-vascular anatomy and visually identify potential risks for stroke and cardiovascular risks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 2260 152nd Avenue North East
  • Suite 200
  • Redmond, WA 98052
  • United States
+1 (425) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VerAvanti Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 29-Apr-2020 00.000 Completed Startup
4. Capitalization 17-Jul-2017 000 00.000 Completed Startup
3. Grant 01-Jun-2017 00000 00000 Completed Startup
2. Angel (individual) 25-May-2017 $540K $540K Completed Startup
1. Accelerator/Incubator 28-Jun-2014 Completed Startup
To view VerAvanti’s complete valuation and funding history, request access »

VerAvanti Patents

VerAvanti Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210239451-A1 Forward looking rgb/optical coherence tomography duplex imager Pending 30-Jan-2020 00000000000
US-11047671-B1 Forward looking rgb/optical coherence tomography duplex imager Active 30-Jan-2020 00000000000
US-9258108-B2 Closed loop, optical feedback synchronization system for imaging applications Active 24-Mar-2014 0000000000
US-20150270945-A1 Closed loop, optical feedback synchronization system for imaging applications Granted 24-Mar-2014 0000000000
CA-2980534-A1 Optical feedback synchronization system for imaging applications Abandoned 24-Mar-2014 H04L7/0075
To view VerAvanti’s complete patent history, request access »

VerAvanti Executive Team (3)

Name Title Board Seat Contact Info
Gerald McMorrow Founder, Board Member & Chief Executive Officer
David Odom Chief Financial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

VerAvanti Board Members (2)

Name Representing Role Since
David Auth Ph.D Self Board Member 000 0000
Frederic Moll MD Self Board Member 000 0000
To view VerAvanti’s complete board members history, request access »

VerAvanti Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VerAvanti Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
UW CoMotion Accelerator/Incubator 000 0000 000000 0
To view VerAvanti’s complete investors history, request access »